Donepezil-induced cervical dystonia in Alzheimer's disease: A case report and literature review of dystonia due to cholinesterase inhibitors

9Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

We herein report an 81-year-old woman with Alzheimer's disease (AD) in who donepezil, a cholinesterase inhibitor (ChEI), caused cervical dystonia. The patient had a two-year history of progressive memory disturbance fulfilling the NINCDS-ADRDA criteria for probable AD. Mini-Mental State Examination score was 19/30. The remaining examination was normal. After a single administration of donepezil (5 mg/day) for 10 months, she complained of dropped head. Neurological examination and electrophysiological studies supported a diagnosis of cervical dystonia. Antecollis disappeared completely at 6 weeks after cessation of donepezil. Dystonic posture can occur at various timings of ChEI use. Physicians should pay more attention to rapidly progressive cervical dystonia in ChEI-treated AD patients. © 2014 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Ikeda, K., Yanagihashi, M., Sawada, M., Hanashiro, S., Kawabe, K., & Iwasaki, Y. (2014). Donepezil-induced cervical dystonia in Alzheimer’s disease: A case report and literature review of dystonia due to cholinesterase inhibitors. Internal Medicine, 53(9), 1007–1010. https://doi.org/10.2169/internalmedicine.53.1857

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free